Radiosynthesis, molecular modeling studies and biological evaluation of 99mTc-Ifosfamide complex as a novel probe for solid tumor imaging
dc.Affiliation | October University for modern sciences and Arts (MSA) | |
dc.contributor.author | Motaleb M.A. | |
dc.contributor.author | El-Safoury D.M. | |
dc.contributor.author | Abd-Alla W.H. | |
dc.contributor.author | Awad G.A.S. | |
dc.contributor.author | Sakr T.M. | |
dc.contributor.other | Labelled Compounds Department | |
dc.contributor.other | Hot Labs Center | |
dc.contributor.other | Atomic Energy Authority | |
dc.contributor.other | Cairo | |
dc.contributor.other | Egypt; Pharmaceutical Chemistry Department | |
dc.contributor.other | College of Pharmaceutical Sciences and Drug Manufacturing | |
dc.contributor.other | Misr University for Science & Technology | |
dc.contributor.other | Giza | |
dc.contributor.other | Egypt; Pharmaceutics and Industrial Pharmacy Department | |
dc.contributor.other | Faculty of Pharmacy | |
dc.contributor.other | Ain Shams University | |
dc.contributor.other | Cairo | |
dc.contributor.other | Egypt; Radioactive Isotopes and Generator Department | |
dc.contributor.other | Hot Labs Center | |
dc.contributor.other | Atomic Energy Authority | |
dc.contributor.other | Cairo | |
dc.contributor.other | Egypt; Pharmaceutical Chemistry Department | |
dc.contributor.other | Faculty of Pharmacy | |
dc.contributor.other | October University of Modern Sciences and Arts (MSA) | |
dc.contributor.other | Giza | |
dc.contributor.other | Egypt | |
dc.date.accessioned | 2020-01-09T20:40:47Z | |
dc.date.available | 2020-01-09T20:40:47Z | |
dc.date.issued | 2018 | |
dc.description | Scopus | |
dc.description | MSA Google Scholar | |
dc.description.abstract | Purpose: Ifosfamide as a chemotherapeutic drug is used for the treatment of different cancer types. The purpose of this study is the preparation of 99mTc-ifosfamide complex to be evaluated as a potential candidate for tumor imaging. Materials and methods: The radiolabeling of ifosfamide with technetium-99m was carried out by mixing 4mg ifosfamide and 5 ?g of SnCl2.2H2O with 400 MBq Na99mTcO4 at pH 9 for 30 min at room temperature. Computer simulation studies were performed using Accelrys Discovery Studio 2.5 operating system to illustrate the interaction of ifosfamide and 99mTc-ifosfamide complexes with DNA. The in-vivo biodistribution of 99mTc-ifosfamide was studied in tumor-bearing Albino mice. Results: A new 99mTc-ifosfamide complex was synthesized with a good radiochemical yield of 90.3. 2.1% under the optimized conditions and exhibited in-vitro stability up to 2 h. Biodistribution studies showed good uptake in tumor site and high uptake in tumor site with T/NT ?3 after 60 min post-injection. Besides, the molecular docking study confirmed that the complexation of ifosfamide with technetium-99m does not abolish its binding to the target receptor. Conclusion: These promising results afford a new radiopharmaceutical that could be used as a potential tumor imaging. 2018, Copyright 2018 Taylor & Francis Group, LLC. | en_US |
dc.description.uri | https://www.scimagojr.com/journalsearch.php?q=29904&tip=sid&clean=0 | |
dc.identifier.doi | https://doi.org/10.1080/09553002.2019.1524945 | |
dc.identifier.doi | PubMed ID 30373490 | |
dc.identifier.issn | 9553002 | |
dc.identifier.other | https://doi.org/10.1080/09553002.2019.1524945 | |
dc.identifier.other | PubMed ID 30373490 | |
dc.identifier.uri | https://t.ly/nv3Mn | |
dc.language.iso | English | en_US |
dc.publisher | Taylor and Francis Ltd | en_US |
dc.relation.ispartofseries | International Journal of Radiation Biology | |
dc.relation.ispartofseries | 94 | |
dc.subject | October University for Modern Sciences and Arts | |
dc.subject | جامعة أكتوبر للعلوم الحديثة والآداب | |
dc.subject | University of Modern Sciences and Arts | |
dc.subject | MSA University | |
dc.subject | Ifosfamide | en_US |
dc.subject | imaging | en_US |
dc.subject | labeling | en_US |
dc.subject | technetium-99m | en_US |
dc.subject | tumor targeting | en_US |
dc.subject | ifosfamide | en_US |
dc.subject | ifosfamide complex tc 99m | en_US |
dc.subject | radiopharmaceutical agent | en_US |
dc.subject | technetium 99m | en_US |
dc.subject | unclassified drug | en_US |
dc.subject | DNA topoisomerase | en_US |
dc.subject | ifosfamide | en_US |
dc.subject | technetium | en_US |
dc.subject | animal experiment | en_US |
dc.subject | animal model | en_US |
dc.subject | animal tissue | en_US |
dc.subject | Article | en_US |
dc.subject | complex formation | en_US |
dc.subject | computer simulation | en_US |
dc.subject | controlled study | en_US |
dc.subject | drug distribution | en_US |
dc.subject | drug DNA interaction | en_US |
dc.subject | drug screening | en_US |
dc.subject | drug stability | en_US |
dc.subject | drug synthesis | en_US |
dc.subject | female | en_US |
dc.subject | in vitro study | en_US |
dc.subject | in vivo study | en_US |
dc.subject | isotope labeling | en_US |
dc.subject | molecular docking | en_US |
dc.subject | molecular imaging | en_US |
dc.subject | molecular model | en_US |
dc.subject | mouse | en_US |
dc.subject | nonhuman | en_US |
dc.subject | priority journal | en_US |
dc.subject | radiochemistry | en_US |
dc.subject | solid malignant neoplasm | en_US |
dc.subject | animal | en_US |
dc.subject | chemistry | en_US |
dc.subject | human | en_US |
dc.subject | kinetics | en_US |
dc.subject | metabolism | en_US |
dc.subject | molecular docking | en_US |
dc.subject | molecular imaging | en_US |
dc.subject | procedures | en_US |
dc.subject | protein domain | en_US |
dc.subject | synthesis | en_US |
dc.subject | tissue distribution | en_US |
dc.subject | Animals | en_US |
dc.subject | DNA Topoisomerases, Type I | en_US |
dc.subject | Drug Stability | en_US |
dc.subject | Humans | en_US |
dc.subject | Ifosfamide | en_US |
dc.subject | Kinetics | en_US |
dc.subject | Mice | en_US |
dc.subject | Molecular Docking Simulation | en_US |
dc.subject | Molecular Imaging | en_US |
dc.subject | Protein Domains | en_US |
dc.subject | Radiochemistry | en_US |
dc.subject | Technetium | en_US |
dc.subject | Tissue Distribution | en_US |
dc.title | Radiosynthesis, molecular modeling studies and biological evaluation of 99mTc-Ifosfamide complex as a novel probe for solid tumor imaging | en_US |
dc.type | Article | en_US |
dcterms.isReferencedBy | Altiparmak, B., Lambrecht, F.Y., Bayrak, E., Durkan, K., Design and synthesis of 99mTc-citro-folate for use as a tumor-targeted radiopharmaceutical (2010) Int J Pharm, 400, pp. 8-14; Al-Wabli, R.I., Sakr, T.M.M.H., Khedr, M.A., Selim, A.A., El-Rahman, M.A.E.-M.A., Zaghary, W.A., Platelet-12 lipoxygenase targeting via newly synthesized curcumin derivative radiolabeled with technetium-99m (2016) Chem Central J, 10, p. 73; Chapman, J.D., Engelhardt, E.L., Stobbe, C.C., Schneider, R.F., Hanks, G.E., Measuring hypoxia and predicting tumor radioresistance with nuclear medicine assays (1998) Radiother Oncol, 46, pp. 229-237; De Barros, A.L., Cardoso, V.N., Mota, L.D., Leite, E.A., dr Oliveira, M.C., Alves, R.J., A novel d-glucose derivative radiolabeled with technetium-99m: synthesis, biodistribution studies and scintigraphic images in an experimental model of Ehrlich tumor (2010) Bioorg Med Chem Lett, 20, pp. 2478-2480; Fukumoto, M., Single-photon agents for tumor imaging: 201Tl, 99mTc-MIBI, and 99mTc-tetrofosmin (2004) Ann Nucl Med, 18, pp. 79-95; Harrison, L., Blackwell, K., Hypoxia and anemia: factors in decreased sensitivity to radiation therapy and chemotherapy (2004) Oncologist, 9, pp. 31-40; Ibrahim, A.B., Sakr, T.M., Khoweysa, O.M.A., Motaleb, M.A., Abd El-Bary, A., El-Kolaly, M.T., Formulation and preclinical evaluation of 99mTc gemcitabine as a novel radiopharmaceutical for solid tumor imaging (2014) J Radioanal Nucl Chem, 302, pp. 179-186; Isarita, M., Jeferson, O.S., Ananda, L.S., Elisabeth, P.V., Alexandre, G., Simultaneous determination of cyclophosphamide and ifosfamide in plasma using SPE-HPLC-UV method (2009) Lat Am J Pharm, 28, pp. 41-46; Junbo, Z., Qian, Y., Jinfeng, H., Yan, P., Sheng, Y., Yining, H., Tingting, T., Xuebin, W., Synthesis and biodistribution of novel 99mTc-DMSA-metronidazole ester as a potential tumor hypoxia imaging agent (2010) J Radioanal Nucl Chem, 283, pp. 481-485; Jurisson, S.S., Lydon, J.D., Potential technetium small molecule radiopharmaceuticals (1999) Chem Rev, 99, pp. 2205-2218; Lettre, R., Paweletz, N., Werner, D., Granzow, C., Sublines of the Ehrlich-Lettr mouse ascites tumour. A new tool for experimental cell research (1972) Naturwissenschaften, 59, pp. 59-63; Lin, J., Qiu, L., Lv, G., Li, K., Wang, W., Liu, G., Zhao, X., Wang, S., Synthesis and preliminary biological evaluation of a 99mTc-chlorambucil derivative as a potential tumor imaging agent (2017) J Label Compd Radiopharm, 60, pp. 116-123; Mohamed, K.O., Nissan, Y.M., El-Malah, A.A., Ahmed, W.A., Ibrahim, D.M., Sakr, T.M., Motaleb, M.A., Design, synthesis and biological evaluation of some novel sulfonamide derivatives as apoptotic agents (2017) Eur J Med Chem, 135, pp. 424-433; Morandeira Rivas, A., Sanchez-Marin, A., Sabench Pereferrer, F., Hernandez Gonzalez, M., del Castillo Dejardin, D., Solid pseudopapillar tumour of the pancreas (2008) Cir Esp, 84, pp. 47-49; Nitiss, J.L., Targeting DNA topoisomerase II in cancer chemotherapy (2009) Nat Rev Cancer, 9, pp. 338-350; Puyo, S., Montaudon, D., Pourquier, P., From old alkylating agents to new minor groove binders (2014) Crit Rev Oncol Hematol, 89, pp. 43-61; Rhodes, B.A., Considerations in the radiolabeling of albumin (1974) Semin Nucl Med, 4, pp. 281-293; Sakr, T.M., El-Safoury, D.M., Awad, G.A., Motaleb, M.A., Biodistribution of 99mTc-sunitinib as a potential radiotracer for tumor hypoxia imaging (2013) J Labelled Comp Radiopharm, 56, pp. 392-395; Sakr, T.M., Essa, B.M., El-Essawy, F.A., El Mohty, A.A., Synthesis and biodistribution of 99mTc-PyDA as a potential marker for tumor hypoxia imaging (2014) Radiochemistry, 56, pp. 76-80; Sakr, T.M., Ibrahim, A.B., Fasih, T.W., Rashed, H.M., Preparation and biological profile of 99mTc-lidocaine as a cardioselective imaging agent using 99mTc eluted from 99Mo/99mTc generator based on Al-Mo gel (2017) J Radioanal Nucl Chem, 314, pp. 2091-2098; Sanad, M.H., Sakr, T.M., Abdel-Hamid, W.H.A., Marzook, E.A., In silico study and biological evaluation of 99mTc-tricabonyl oxiracetam as a selective imaging probe for AMPA receptors (2017) J Radioanal Nucl Chem, 314, pp. 1505-1515; Santos-Cuevas, C.L., Ferro-Flores, G., Arteaga de Murphy, C., Ramrez, F., de, M., Luna-Gutirrez, M.A., Pedraza-Lpez, M., Ordaz-Rosado, D., Design, preparation, in vitro and in vivo evaluation of 99mTc-N2S2-Tat(49-57)-bombesin: a target-specific hybrid radiopharmaceutical (2009) Int J Pharm, 375, pp. 75-83; Schottelius, M., Wester, H.J., Molecular imaging targeting peptide receptors (2009) Methods, 48, pp. 161-177; Sheeja, K.R., Kuttan, G., Kuttan, R., Cytotoxic and antitumour activity of Berberin (1997) Amala Res Bull, 17, pp. 73-76; Sun, X., Niu, G., Chan, N., Shen, B., Chen, X., Tumor hypoxia imaging (2011) Mol Imaging Biol, 13, pp. 399-410; Wang, J., Yang, J., Yan, Z., Duan, X., Tan, C., Shen, Y., Wu, W., Synthesis and preliminary biological evaluation of [99mTc(CO)3(IDAPEG3CB)]? for tumor imaging (2011) J Radioanal Nucl Chem, 287, pp. 465-469 | |
dcterms.source | Scopus |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- avatar_scholar_256.png
- Size:
- 6.31 KB
- Format:
- Portable Network Graphics
- Description: